4qkh - Revision history

OCA at 15:07, 8 November 2023

OCA — Wed, 08 Nov 2023 15:07:31 GMT

←Older revision		Revision as of 15:07, 8 November 2023
Line 4:		Line 4:
	== Structural highlights ==		== Structural highlights ==
	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4QKH FirstGlance]. <br>		<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4QKH FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>	+	</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.8Å</td></tr>
		+	<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [https://pdbe.org/4qkh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [https://www.ebi.ac.uk/pdbsum/4qkh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4qkh ProSAT]</span></td></tr>		<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [https://pdbe.org/4qkh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [https://www.ebi.ac.uk/pdbsum/4qkh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4qkh ProSAT]</span></td></tr>
	</table>		</table>

OCA at 11:33, 15 February 2023

OCA — Wed, 15 Feb 2023 11:33:29 GMT

←Older revision		Revision as of 11:33, 15 February 2023
Line 1:		Line 1:

	==Dimeric form of human LLT1, a ligand for NKR-P1==		==Dimeric form of human LLT1, a ligand for NKR-P1==
-	<StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution\|resolution]] 1.80Å' scene=''>	+	<StructureSection load='4qkh' size='340' side='right'caption='[[4qkh]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure with sequence from [~~http~~://en.wikipedia.org/wiki/~~Human Human~~]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4QKH FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4QKH FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>~~</td></tr>~~	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	~~<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>~~	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [https://pdbe.org/4qkh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [https://www.ebi.ac.uk/pdbsum/4qkh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4qkh ProSAT]</span></td></tr>
-	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CLAX, CLEC2B, CLEC2D, LLT1, OCIL ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>	+
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[~~http~~://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [~~http~~://pdbe.org/4qkh PDBe], [~~http~~://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [~~http~~://www.ebi.ac.uk/pdbsum/4qkh PDBsum], [~~http~~://prosat.h-its.org/prosat/prosatexe?pdbcode=4qkh ProSAT]</span></td></tr>	+
	</table>		</table>
	== Function ==		== Function ==
-	[~~[http~~://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>	+	[https://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
	== Publication Abstract from PubMed ==		== Publication Abstract from PubMed ==
Line 24:		Line 22:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
-	[[Category: ~~Human~~]]	+	[[Category: Homo sapiens]]
-	[[Category: Blaha, J]]	+	[[Category: Large Structures]]
-	[[Category: Dohnalek, J]]	+	[[Category: Blaha J]]
-	[[Category: Duskova, J]]	+	[[Category: Dohnalek J]]
-	[[Category: Harlos, K]]	+	[[Category: Duskova J]]
-	[[Category: Hasek, J]]	+	[[Category: Harlos K]]
-	[[Category: Koval, T]]	+	[[Category: Hasek J]]
-	[[Category: Skalova, T]]	+	[[Category: Koval T]]
-	[[Category: Stransky, J]]	+	[[Category: Skalova T]]
-	[[Category: Vanek, O]]	+	[[Category: Stransky J]]
-	~~[[Category: Anchored in membrane on cell surface]]~~	+	[[Category: Vanek O]]
-	~~[[Category: C-type lectin like fold]]~~	+
-	~~[[Category: Deglycosylated after the first glcnac unit]]~~	+
-	~~[[Category: Glycosylation]]~~	+
-	~~[[Category: Immune system]]~~	+
-	~~[[Category: Ligand for human receptor nkr-p1~~]]	+

OCA at 07:57, 14 June 2018

OCA — Thu, 14 Jun 2018 07:57:18 GMT

←Older revision		Revision as of 07:57, 14 June 2018
Line 1:		Line 1:
		+
	==Dimeric form of human LLT1, a ligand for NKR-P1==		==Dimeric form of human LLT1, a ligand for NKR-P1==
	<StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution\|resolution]] 1.80Å' scene=''>		<StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution\|resolution]] 1.80Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance]. <br>
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://pdbe.org/4qkh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr>	+	<tr id='gene'><td class="sblockLbl"><b>[[Gene\|Gene:]]</b></td><td class="sblockDat">CLAX, CLEC2B, CLEC2D, LLT1, OCIL ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr>
		+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://pdbe.org/4qkh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4qkh ProSAT]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
Line 22:		Line 24:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
	[[Category: Blaha, J]]		[[Category: Blaha, J]]
	[[Category: Dohnalek, J]]		[[Category: Dohnalek, J]]

OCA at 18:41, 27 January 2016

OCA — Wed, 27 Jan 2016 18:41:35 GMT

←Older revision		Revision as of 18:41, 27 January 2016
Line 5:		Line 5:
	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>		</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>		<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://pdbe.org/4qkh PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr>
	</table>		</table>
	== Function ==		== Function ==
	[[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>		[[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>
		+	<div style="background-color:#fffaf0;">
		+	== Publication Abstract from PubMed ==
		+	Human LLT1 is a C-type lectin-like ligand of NKR-P1 (CD161, gene KLRB1), a C-type lectin-like receptor of natural killer cells. Using X-ray diffraction, the first experimental structures of human LLT1 were determined. Four structures of LLT1 under various conditions were determined: monomeric, dimeric deglycosylated after the first N-acetylglucosamine unit in two forms and hexameric with homogeneous GlcNAc2Man5 glycosylation. The dimeric form follows the classical dimerization mode of human CD69. The monomeric form keeps the same fold with the exception of the position of an outer part of the long loop region. The hexamer of glycosylated LLT1 consists of three classical dimers. The hexameric packing may indicate a possible mode of interaction of C-type lectin-like proteins in the glycosylated form.
		+
		+	Four crystal structures of human LLT1, a ligand of human NKR-P1, in varied glycosylation and oligomerization states.,Skalova T, Blaha J, Harlos K, Duskova J, Koval' T, Stransky J, Hasek J, Vanek O, Dohnalek J Acta Crystallogr D Biol Crystallogr. 2015 Mar;71(Pt 3):578-91. doi:, 10.1107/S1399004714027928. Epub 2015 Feb 26. PMID:25760607<ref>PMID:25760607</ref>
		+
		+	From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
		+	</div>
		+	<div class="pdbe-citations 4qkh" style="background-color:#fffaf0;"></div>
	== References ==		== References ==
	<references/>		<references/>

OCA at 11:55, 11 March 2015

OCA — Wed, 11 Mar 2015 11:55:17 GMT

←Older revision		Revision as of 11:55, 11 March 2015
Line 1:		Line 1:
-	'''~~Unreleased structure~~'''	+	==Dimeric form of human LLT1, a ligand for NKR-P1==
-		+	<StructureSection load='4qkh' size='340' side='right' caption='[[4qkh]], [[Resolution\|resolution]] 1.80Å' scene=''>
-	~~The entry~~ 4qkh is ~~ON HOLD until Paper Publication~~	+	== Structural highlights ==
-		+	<table><tr><td colspan='2'>[[4qkh]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4QKH OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4QKH FirstGlance]. <br>
-	~~Authors~~: ~~Skalova~~, T., ~~Blaha, J~~.~~, Harlos, K~~.~~, Duskova, J~~.~~, Koval, T~~., ~~Stransky, J~~.~~, Hasek, J~~., ~~Vanek, O~~., ~~Dohnalek, J~~.	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-		+	<tr id='related'><td class="sblockLbl"><b>[[Related_structure\|Related:]]</b></td><td class="sblockDat">[[4qkg\|4qkg]], [[4qki\|4qki]], [[4qkj\|4qkj]]</td></tr>
-	~~Description~~: ~~Dimeric form of human LLT1, a ligand~~ for ~~NKR~~-P1	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4qkh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4qkh OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4qkh RCSB], [http://www.ebi.ac.uk/pdbsum/4qkh PDBsum]</span></td></tr>
-	[[Category: ~~Unreleased Structures~~]]	+	</table>
		+	== Function ==
		+	[[http://www.uniprot.org/uniprot/CLC2D_HUMAN CLC2D_HUMAN]] Receptor for KLRB1 that protects target cells against natural killer cell-mediated lysis. Inhibits osteoclast formation. Inhibits bone resorption. Modulates the release of interferon-gamma. Binds high molecular weight sulfated glycosaminoglycans.<ref>PMID:14753741</ref> <ref>PMID:15104121</ref> <ref>PMID:16339513</ref>
		+	== References ==
		+	<references/>
		+	__TOC__
		+	</StructureSection>
		+	[[Category: Blaha, J]]
	[[Category: Dohnalek, J]]		[[Category: Dohnalek, J]]
	[[Category: Duskova, J]]		[[Category: Duskova, J]]
	[[Category: Harlos, K]]		[[Category: Harlos, K]]
-	[[Category: Stransky, J]]
-	[[Category: Blaha, J]]
-	[[Category: Vanek, O]]
	[[Category: Hasek, J]]		[[Category: Hasek, J]]
	[[Category: Koval, T]]		[[Category: Koval, T]]
	[[Category: Skalova, T]]		[[Category: Skalova, T]]
		+	[[Category: Stransky, J]]
		+	[[Category: Vanek, O]]
		+	[[Category: Anchored in membrane on cell surface]]
		+	[[Category: C-type lectin like fold]]
		+	[[Category: Deglycosylated after the first glcnac unit]]
		+	[[Category: Glycosylation]]
		+	[[Category: Immune system]]
		+	[[Category: Ligand for human receptor nkr-p1]]

OCA at 07:59, 12 February 2015

OCA — Thu, 12 Feb 2015 07:59:12 GMT

←Older revision		Revision as of 07:59, 12 February 2015
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

-	The entry 4qkh is ON HOLD	+	The entry 4qkh is ON HOLD until Paper Publication

	Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J.		Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J.

OCA at 15:52, 24 December 2014

OCA — Wed, 24 Dec 2014 15:52:29 GMT

←Older revision		Revision as of 15:52, 24 December 2014
Line 6:		Line 6:

	Description: Dimeric form of human LLT1, a ligand for NKR-P1		Description: Dimeric form of human LLT1, a ligand for NKR-P1
		+	[[Category: Unreleased Structures]]
		+	[[Category: Dohnalek, J]]
		+	[[Category: Duskova, J]]
		+	[[Category: Harlos, K]]
		+	[[Category: Stransky, J]]
		+	[[Category: Blaha, J]]
		+	[[Category: Vanek, O]]
		+	[[Category: Hasek, J]]
		+	[[Category: Koval, T]]
		+	[[Category: Skalova, T]]

OCA: Protected "4qkh" [edit=sysop:move=sysop]

OCA — Wed, 11 Jun 2014 08:10:28 GMT

Protected "4qkh" [edit=sysop:move=sysop]

←Older revision

Revision as of 08:10, 11 June 2014

OCA: New page: '''Unreleased structure''' The entry 4qkh is ON HOLD Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J. Description: ...

OCA — Wed, 11 Jun 2014 08:10:26 GMT

New page: '''Unreleased structure''' The entry 4qkh is ON HOLD Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J. Description: ...

New page

'''Unreleased structure'''

The entry 4qkh is ON HOLD

Authors: Skalova, T., Blaha, J., Harlos, K., Duskova, J., Koval, T., Stransky, J., Hasek, J., Vanek, O., Dohnalek, J.

Description: Dimeric form of human LLT1, a ligand for NKR-P1